Clinical Trial Applications: Filter, Search, and view applications

Extended search...

Page 1 of 54, showing 5 Applications out of 267 total, starting on record 1, ending on 5

# Protocol No Study Title Investigator(s) & Site(s) Application Status


    The effect of fractional doses of pneumococcal conjugate vaccines (PCV10 and PCV13) on immunogenicity and vaccine-serotype carriage in Kenyan infants       
Principal Investigator(s)
1. Anthony John Scott
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
Trial Status Recruiting
Protocol Date 09-01-2018


ECCT/19/03/04   NIFTY
      Non-Inferiority Fractional-Doses Trial For Yellow Fever Vaccine         
Principal Investigator(s)
1. George Warimwe
Site(s) in Kenya
KEMRI Kilifi
Trial Status In follow-up
Protocol Date 04-03-2019


ECCT/19/07/01   IMPROVE-2
      chemoprevention with monthly IPTp with dihydroartemisinin-piperaquine for malaria in HIV-infected pregnant participants on daily cotrimoxazole in Kenya and Malawi: a multi-centre placebo-controlled trial(IMPROVE-2).    
Principal Investigator(s)
1. Hellen Cherono Barsosio
2. Simon Kariuki
Site(s) in Kenya
1. Ahero Sub-County Hospital (Kisumu county)
2. Rabuor Sub-County Hospital (Kisumu county)
3. Akala Sub-County Hospital (Siaya county)
Trial Status Recruiting
Protocol Date 17-05-2019


ECCT/19/06/03   Evaluation of the RTS,S vaccine implementation in Kenya (MVPE)
      An evaluation of the cluster-randomised pilot implementation of the RTS,S/AS01 malaria vaccine through routine health systems in western Kenya         
Principal Investigator(s)
1. Aaron Samuels Samuels
Site(s) in Kenya
1. Bungoma County (Bung\'oma county)
2. Busia County (Busia county)
3. Homa Bay (Homa Bay county)
4. Kakamega County (Kakamega county)
5. Kisumu County (Kisumu county)
6. Migori County (Migori county)
7. Siaya County (Siaya county)
8. Vihiga County (Vihiga county)
Trial Status Recruiting
Protocol Date 11-03-2019


ECCT/16/10/02   PAINT Study
    A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral-naïve HIV-1 infected adolescents and children aged ≥6 to <18 years   
Principal Investigator(s)
1. Professor Walter Jaoko
Site(s) in Kenya
1. KAVI Institute of Clinical Research (Nairobi City county)
2. Kenya Medical Research Institute/Walter Reed Project, HIV Program (Kericho county)
Trial Status Recruiting
Protocol Date 18-12-2015